A study on the establishment of periodontal treatment for patients with insulin resistant diabetes mellitus.

胰岛素抵抗糖尿病患者牙周治疗方案建立的研究

基本信息

批准号：
12470470
负责人：
MURAYAMA Yoji
金额：
$ 9.28万
依托单位：
OKAYAMA UNIVERSITY
依托单位国家：
日本
项目类别：
Grant-in-Aid for Scientific Research (B)
财政年份：
2000
资助国家：
日本
起止时间：
2000 至 2001
项目状态：
已结题

来源：
https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-12470470/
关键词：
type 2 diabetes obesity insulin resistance TNF-α periodontitis type 1 diabetes sero-diagnosis GAD antibody 生活習慣病歯周病疑陽性

项目摘要

The number of diabetes increased markedly due possibly to the rapid change of our lifestyle, and to the increase in obese subjects with insulin resistance. Tumor necrosis factor-α (TNF-α) produced from adipocytes in the adipose tissues has been suggested to be affect insulin resistance in obese subjects. Apart from adipocytes, activated macrophages infiltrated in inflammatory lesion also produce large quantity of TNF-α. Based on these backgrounds, we hypothesized that successful periodontal treatment in diabetes patients may result in decrease in circulating TNF-α and subsequent metabolic control of diabetes. The results indicated that anti-microbial periodontal treatment resulted in marked decrease in 1) the number of microorganism in periodontal pockets and 2) circulating TNF-α concentration, and in significant improvement in 3) insulin resistance and 4) subsequent metabolic control.We also found that some periodontitis patients exhibited increased anti-GAD antibody which is widely used as a sero-diagnostic marker in patients with type 1 diabetes. Generally, GAD is known to be produced in pancreatic β-cells and some nerve cells. However, we also found that fibroblastic cells including gingival fibroblasts express GAD both at gene and protein level. Thus, we thought that periodontal inflammation which destruct periodontal connective tissues resulted in the release of GAD and in exposure of such GAD to immune cells, led to the production of anti-GAD antibodies. Therefore, it is possible that periodontal inflammation influences sero-diagnosis of type 1 diabetes.These results indicate that diabetes not only influence the susceptibility and progression of periodontitis, but periodontal inflammation also influences diabetic status. Thus, it can be concluded that periodontitis is an important complication of diabetes modulating the clinical course and diagnostic procedure of diabetes.

糖尿病的数量明显增加，这是由于我们的生活方式的快速变化以及胰岛素抵抗的肥胖受试者的增加。已经建议在脂肪组织中脂肪细胞产生的肿瘤坏死因子-α（TNF-α）会影响肥胖受试者的胰岛素抵抗。除脂肪细胞外，在炎症病变中浸润的活化巨噬细胞还会产生大量的TNF-α。基于这些背景，我们假设糖尿病患者的成功牙周治疗可能导致循环TNF-α以及随后对糖尿病的代谢控制的减少。 The results indicated that anti-microbial periodontal treatment resulted in marked decrease in 1) the number of microorganism in periodontal pockets and 2) circulating TNF-α concentration, and in significant improvement in 3) insulin resistance and 4) subsequent metabolic control.We also found that some periodontitis patients exposed increased anti-GAD antibody which is widely used as a sero-diagnostic marker in patients with type 1个糖尿病。通常，已知GAD是在胰腺β细胞和一些神经细胞中产生的。但是，我们还发现成纤维细胞在基因和蛋白质水平上表达GAD。这就是我们认为，破坏牙周结缔组织的牙周炎症导致GAD释放并暴露于这种GAD向免疫细胞暴露，从而产生了抗GAD抗体的产生。因此，牙周感染可能会影响1型糖尿病的血清诊断。这些结果表明，糖尿病不仅影响牙周炎的敏感性和进展，而且牙周感染也会影响糖尿病状况。这可以得出结论，牙周炎是调节糖尿病临床病程和诊断程序的糖尿病的重要并发症。